No we shouldn't be afraid of medical AI; it involves risks and opportunities.

In contrast to Di Nucci's characterisation, my argument is not a technoapocalyptic one. The view I put forward is that systems like IBM's Watson for Oncology create both risks and opportunities from the perspective of shared decision-making. In this response, I address the issues that Di Nucci raises and highlight the importance of bioethicists engaging critically with these developing technologies. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.